Original price was: $1,899.00.$1,859.00Current price is: $1,859.00.
In Stock
Kyprolis, in combination with daratumumab and dexamethasone, with lenalidomide and dexamethasone, is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior line of anticancer therapy.
Kyprolis monotherapy for relapsed and refractory multiple myeloma in patients who have received at least 2 previous lines of therapy, including bortezomib and an immunomodulatory agent.
Active ingredient: carfilzomib
Prescription drug
